Worth, C., Al-Mossawi, M., MacDonald, J., Fisher, B., Chan, A., Sengupta, R., . . . Bowness, P. (2024). Granulocyte-macrophage colony-stimulating factor neutralisation in patients with axial spondyloarthritis in the UK (NAMASTE): A randomised, double-blind, placebo-controlled, phase 2 trial. Elsevier.
Chicago Style (17th ed.) CitationWorth, C., et al. Granulocyte-macrophage Colony-stimulating Factor Neutralisation in Patients with Axial Spondyloarthritis in the UK (NAMASTE): A Randomised, Double-blind, Placebo-controlled, Phase 2 Trial. Elsevier, 2024.
ציטוט MLAWorth, C., et al. Granulocyte-macrophage Colony-stimulating Factor Neutralisation in Patients with Axial Spondyloarthritis in the UK (NAMASTE): A Randomised, Double-blind, Placebo-controlled, Phase 2 Trial. Elsevier, 2024.